CFDE Data Portal | Search UBE2V1

	Label	Description
	UBE2V1 Gene (Entity type)	ENSG00000244687 - ubiquitin conjugating enzyme E2 V1
	UBE2V1 associations Collection (Entity type)	Associations for UBE2V1_associations
	UBE2V1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE240439 decitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 2 V 4 DEXAMETHASONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	TMEM189-UBE2V1 associations Collection (Entity type)	Associations for TMEM189-UBE2V1_associations
	PEDS1-UBE2V1 Gene (Entity type)	ENSG00000124208 - PEDS1-UBE2V1 readthrough
	GSE158834 0 V 4 PALMITIC ACID HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

UBE2V1

ENSG00000244687 - ubiquitin conjugating enzyme E2 V1

UBE2V1 associations

Associations for UBE2V1_associations

UBE2V1 associations.tsv

A file from IDG as part of the Harmonizome project

GSE240439 decitabine 1 v 2 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human dn

A Gene Set from LINCS

GSE135350 2 V 4 DEXAMETHASONE HUMAN DN

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up

A Gene Set from LINCS

TMEM189-UBE2V1 associations

Associations for TMEM189-UBE2V1_associations

PEDS1-UBE2V1

ENSG00000124208 - PEDS1-UBE2V1 readthrough

GSE158834 0 V 4 PALMITIC ACID HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.